Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?
Psilocybin shows promise as a multidimensional therapy for chronic pain, addressing both sensory and affective components. However, ethical issues, safety concerns, and regulatory barriers necessitate careful management, and robust randomized controlled trials are essential to confirm efficacy and guide clinical translation.
Authors
- Silvia Natoli (ORCID: https://orcid.org/0000-0003-3758-5375)
- Maurizio Marchesini (ORCID: https://orcid.org/0000-0002-3286-9531)
- Vittorio Guardamagna (ORCID: https://orcid.org/0000-0002-3554-8151)
- Arturo Cuomo (ORCID: https://orcid.org/0000-0002-1165-6713)
- Livio Luongo (ORCID: https://orcid.org/0000-0002-1949-2039)
- Giuliano Lo Bianco (ORCID: https://orcid.org/0000-0003-2705-1548)
- Shigeki Yamaguchi (ORCID: https://orcid.org/0000-0003-3850-2818)
Institutions
- University of Campania "Luigi Vanvitelli" (IT)
- University of Pavia (IT)
- Fondazione Istituto G. Giglio di Cefalù (IT)
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- European Institute of Oncology (IT)
- Dokkyo Medical University (JP)
Publication Details
- Journal
- Medical Sciences
- Published
- 2025-11-20
- DOI
- https://doi.org/10.3390/medsci13040277
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00